-
1
-
-
78650976096
-
-
(consulté en mai 2010).
-
(consulté en mai 2010). http://www.idf.org/webdata/docs/Metabolic_syndrome_definition.pdf.
-
-
-
-
3
-
-
77956339546
-
-
et al. Association between metabolic syndrome and liver histology among children with non-alcoholic fatty liver disease. Am J Gastroenterol
-
Patton HM, Yates K, Unalp-Arida A, et al. Association between metabolic syndrome and liver histology among children with non-alcoholic fatty liver disease. Am J Gastroenterol 2010;105:2093-102.
-
(2010)
, vol.105
, pp. 2093-102
-
-
Patton, H.M.1
Yates, K.2
Unalp-Arida, A.3
-
4
-
-
70249094340
-
Pediatric non-alcoholic fatty liver disease in 2009
-
Alisi A., Manco M., Vania A., et al. Pediatric non-alcoholic fatty liver disease in 2009. J Pediatr 2009, 155:469-474.
-
(2009)
J Pediatr
, vol.155
, pp. 469-474
-
-
Alisi, A.1
Manco, M.2
Vania, A.3
-
6
-
-
47649097839
-
Association of arterial stiffness and endothelial dysfunction with metabolic syndrome in obese children
-
Mimoun E., Aggoun Y., Pousset M., et al. Association of arterial stiffness and endothelial dysfunction with metabolic syndrome in obese children. J Pediatr 2008, 153:65-70.
-
(2008)
J Pediatr
, vol.153
, pp. 65-70
-
-
Mimoun, E.1
Aggoun, Y.2
Pousset, M.3
-
7
-
-
33746415251
-
Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes
-
Eppens M.C., Craig M.E., Cusumano J., et al. Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes care 2006, 29:1300-1306.
-
(2006)
Diabetes care
, vol.29
, pp. 1300-1306
-
-
Eppens, M.C.1
Craig, M.E.2
Cusumano, J.3
-
8
-
-
33750002388
-
Prevalence of fatty liver in children and adolescents
-
Schwimmer J.B., Deutsch R., Kahen T., et al. Prevalence of fatty liver in children and adolescents. Pediatrics 2006, 118:1388-1393.
-
(2006)
Pediatrics
, vol.118
, pp. 1388-1393
-
-
Schwimmer, J.B.1
Deutsch, R.2
Kahen, T.3
-
9
-
-
70350077457
-
Non-alcoholic steatohepatitis in children: a multicenter clinicopathological study
-
Carter-Kent C., Yerian L.M., Brunt E.M., et al. Non-alcoholic steatohepatitis in children: a multicenter clinicopathological study. Hepatology 2009, 50:1113-1120.
-
(2009)
Hepatology
, vol.50
, pp. 1113-1120
-
-
Carter-Kent, C.1
Yerian, L.M.2
Brunt, E.M.3
-
10
-
-
0031947715
-
Steatohepatitis: a tale of two "hits" ?
-
Day C.P., James O.F. Steatohepatitis: a tale of two "hits" ?. Gastroenterology 1998, 114:8425.
-
(1998)
Gastroenterology
, vol.114
, pp. 8425
-
-
Day, C.P.1
James, O.F.2
-
12
-
-
33845262498
-
Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease
-
Nobili V., Manco M., Ciampalini P., et al. Leptin, free leptin index, insulin resistance and liver fibrosis in children with non-alcoholic fatty liver disease. Eur J Endocrinol 2006, 155:735-743.
-
(2006)
Eur J Endocrinol
, vol.155
, pp. 735-743
-
-
Nobili, V.1
Manco, M.2
Ciampalini, P.3
-
13
-
-
63349097089
-
Liver biopsy. American association for the study of liver diseases
-
Rockey D.C., Caldwell S.H., Goodman Z.D., et al. Liver biopsy. American association for the study of liver diseases. Hepatology 2009, 49:1017-1044.
-
(2009)
Hepatology
, vol.49
, pp. 1017-1044
-
-
Rockey, D.C.1
Caldwell, S.H.2
Goodman, Z.D.3
-
14
-
-
34247643846
-
Pediatric non-alcoholic fatty liver disease (NAFLD): a "growing" problem?
-
Roberts E.A. Pediatric non-alcoholic fatty liver disease (NAFLD): a "growing" problem?. J Hepatol 2007, 46:1133-1142.
-
(2007)
J Hepatol
, vol.46
, pp. 1133-1142
-
-
Roberts, E.A.1
-
15
-
-
67649306197
-
Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis
-
Argo C.K., Northup P.G., Al-Osaimi A.M.S., et al. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol 2009, 51:371-379.
-
(2009)
J Hepatol
, vol.51
, pp. 371-379
-
-
Argo, C.K.1
Northup, P.G.2
Al-Osaimi, A.M.S.3
-
17
-
-
77951874018
-
Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis
-
Sanyal A.J., Chalasani N., Kowdley K.V., et al. Pioglitazone, vitamin E, or placebo for non-alcoholic steatohepatitis. N Engl J Med 2010, 362:1675-1685.
-
(2010)
N Engl J Med
, vol.362
, pp. 1675-1685
-
-
Sanyal, A.J.1
Chalasani, N.2
Kowdley, K.V.3
-
18
-
-
0037566201
-
Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values
-
Mofrad P., Contos M.J., Haque M., et al. Clinical and histologic spectrum of non-alcoholic fatty liver disease associated with normal ALT values. Hepatology 2003, 37:1286-1292.
-
(2003)
Hepatology
, vol.37
, pp. 1286-1292
-
-
Mofrad, P.1
Contos, M.J.2
Haque, M.3
-
19
-
-
59849117801
-
Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease
-
Nobili V., Parkes J., Bottazzo G., et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. Gastroenterology 2009, 136:160-167.
-
(2009)
Gastroenterology
, vol.136
, pp. 160-167
-
-
Nobili, V.1
Parkes, J.2
Bottazzo, G.3
-
20
-
-
49649105500
-
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric non-alcoholic steatohepatitis
-
Nobili V., Vizzutti F., Arena U., et al. Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric non-alcoholic steatohepatitis. Hepatology 2008, 48:442-448.
-
(2008)
Hepatology
, vol.48
, pp. 442-448
-
-
Nobili, V.1
Vizzutti, F.2
Arena, U.3
|